Related Experiment Video
Updated: Apr 18, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
Adenosine 2A receptors modulate reward behaviours for methamphetamine.
Rose Chesworth1,2, Robyn M Brown1,2,3, Jee Hyun Kim1,2
1Behavioural Neuroscience Division, Florey Institute of Neuroscience and Mental Health, Australia.
Adenosine 2A (A2 A) receptor signaling is crucial for methamphetamine addiction. A2 A knockout mice showed reduced motivation for METH, suggesting A2 A receptors as a potential therapeutic target.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Methamphetamine (METH) addiction lacks effective pharmacotherapies.
- Adenosine 2A (A2 A) receptors modulate dopamine and glutamate, impacting reward pathways.
- The role of A2 A receptors in METH addiction is largely unexplored.
Purpose of the Study:
- To investigate the role of A2 A receptors in METH addiction behaviors using A2 A knockout (KO) mice.
- To determine if A2 A receptor signaling influences METH consumption, seeking, and motivation.
Main Methods:
- Utilized A2 A knockout (KO) and wild-type (WT) littermate mice.
- Assessed METH conditioned place preference.
- Examined locomotor sensitization following repeated METH administration.
- Measured METH and sucrose self-administration under various reinforcement schedules.
Main Results:
- A2 A KO mice did not develop METH conditioned place preference.
- Locomotor sensitization to METH was attenuated in A2 A KO mice.
- While METH self-administration was intact, motivation to self-administer METH was reduced in A2 A KO mice.
- Reduced motivation for METH and sucrose was observed in A2 A KO mice.
Conclusions:
- A2 A receptor signaling is essential for the rewarding and motivational aspects of METH addiction.
- A2 A receptors play a critical role in integrating the rewarding properties of both METH and natural rewards.
- Targeting A2 A receptors may offer a novel therapeutic strategy for METH addiction.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Drugs Affecting Neurotransmitter Release or Uptake
Drug Abuse and Addiction: Pharmacological Phenomena